𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Corticosteroid maintenance therapy for Crohn's disease—not yet!

✍ Scribed by Samuel Meyers

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
234 KB
Volume
2
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Budesonide induction and maintenance the
Budesonide induction and maintenance therapy for Crohn's disease during pregnancy
✍ Dawn B. Beaulieu; Ashwin N. Ananthakrishnan; Mazen Issa; Lydia Rosenbaum; Sue Sk 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

Background: There is no standard approach for the medical management of Crohn's disease (CD) during pregnancy and there is limited data regarding safety and efficacy of the treatments. Budesonide (Entocort EC, AstraZeneca) is an enteric coated locally acting glucocorticoid preparation whose pH-and t

Do patients consider postoperative maint
Do patients consider postoperative maintenance therapy for Crohn's disease worthwhile?
✍ Erin D. Kennedy; Theresa To; A. Hillary Steinhart; Allan Detsky; Hilary A. Llewe 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 1 views

## Background: Treatment decision making for postoperative Crohn's disease is complex because of the increasing number of maintenance therapies available with competing risk-benefit profiles. The main objective of this study was to determine the distribution of patients' preferences for selected po

Postoperative therapy for Crohn's diseas
Postoperative therapy for Crohn's disease
✍ Eric Blum; Jeffry A. Katz 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Prevention of the postoperative recurrence of Crohn's disease (CD) remains a challenging clinical problem. The majority of patients with CD will need surgery for treatment of the disease, most of these patients will develop recurrent symptoms within 5 years postoperatively, and many patients will ne